by PEPID Newsroom | Nov 20, 2018 | Alerts
The FDA approved Aemcolo (rifamycin) yesterday for the treatment of travelers’ diarrhea. Aemcolo is an antibacterial drug to treat noninvasive strains of Escherichia coli (E. coli) not complicated by fever or blood in the stool. The FDA estimates 10-40% of travelers...
by PEPID Newsroom | Nov 14, 2018 | Alerts
FDA approves a new version of Primatene Mist, the only OTC metered-dose inhaler. Primatene Mist is approved by the FDA as an OTC drug to provide temporary relief for symptoms of mild, intermittent asthma. Primatene Mist is only approved for those who have been...
by PEPID Newsroom | Nov 9, 2018 | Alerts
The FDA announced emergency use authorization for a rapid, single-use test to detect the Ebola Virus (Zaire ebolavirus). The test, called the DPP Ebola Antigen System (Chembio Diagnostic Systems Inc), is novel for using a portable battery reader for accurate...
by PEPID Newsroom | Nov 9, 2018 | Alerts
A French study finds an association between a higher frequency of organic food consumption and a reduced risk of cancer. The study findings still need to be confirmed. In this population-based cohort study of 68,947 French adults, high organic food scores were...
by PEPID Newsroom | Nov 7, 2018 | Alerts
A cohort study by the United Kingdom Clinical Research Datalink associated the use of ACEIs with an increased risk of lung cancer. The association elevated among people using ACE Inhibitors for more than five years. The study consisted of 992,061 patients treated with...
